Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression

Area of Science:

• Oncology
• Cancer Biology
• Molecular Mechanisms

Background:

• Tumor classification into subtypes aids diagnosis and targeted therapy.
• Next-generation sequencing reveals greater cancer phenotype heterogeneity, necessitating updated classifications.
• Tumors are dynamic, evolving and changing characteristics during progression and in response to therapy.

Purpose of the Study:

• To discuss tumor subtype transitions as an emerging hallmark of cancer.
• To explore the molecular mechanisms underlying these transitions at the tumor-microenvironment interface.
• To focus on four specific human cancers exhibiting tissue plasticity-driven subtype switching.

Main Methods:

• Review of current literature on cancer subtype heterogeneity and plasticity.
• Analysis of molecular mechanisms driving transdifferentiation in cancer cells.
• Case study focus on breast cancer, prostate cancer, glioblastoma, and pancreatic adenocarcinoma.

Main Results:

• Cancer cells can transdifferentiate, changing subtype to adapt to microenvironments.
• These modifications influence tumor growth rate, invasiveness, and treatment response.
• Tissue plasticity is a significant factor in tumor subtype switching in the studied cancers.

Conclusions:

• Studying tumor subtype transitions is crucial for understanding tumor evolution.
• Predicting disease outcomes and developing personalized treatment strategies rely on this understanding.
• Targeting the plasticity and molecular mechanisms of subtype transitions offers new therapeutic avenues.